Prime Medicine PRME
NASDAQ PRME
$4.30 +0.40 (+10.26%)
At close: Nov 11, 2026 · 4:00 PM EST

Prime Medicine (PRME) Change in Receivables (2024 - 2025)

Updated

Prime Medicine's Change in Receivables came in at -$120,000 for Q3 2025, compared with $55 million a year earlier.

Analysis

Prime Medicine (PRME) Change in Receivables (2024 - 2025) Analysis & Trends

Going back to Q3 2024, Prime Medicine's Change in Receivables data covers 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -188.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -312.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 108.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -52.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Prime Medicine 704.88 Mn 469.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 103,000.00
Mar 31, 2025 17,000.00
Sep 30, 2024 55.00 Mn
API Access

Prime Medicine Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=PRME&period=max&api_key=YOUR_API_KEY